Publication | Open Access

Meloxicam protects cell damage from 1-methyl-4-phenyl pyridinium toxicity via the phosphatidylinositol 3-kinase/Akt pathway in human dopaminergic neuroblastoma SH-SY5Y cells

Cell DamageMedicineCell DeathNeuroprotectionAnti-cancer AgentCell BiologyTumor SuppressorPhosphatidylinositol 3-Kinase/akt PathwayPharmacologyGliomaTumor Microenvironment1-Methyl-4-phenyl Pyridinium ToxicityOxidative Stress